The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

The biotech industry can be volatile even for relatively large companies. Amgen (NASDAQ: AMGN), one of the more prominent ...

Armed with results from a phase 2 trial, Boehringer Ingelheim has said it will take its obesity drug candidate survodutide into a phase 3 programme later this year. The glucagon/GLP-1 receptor ...

The first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after the US Food and Drug Administration granted it a breakthrough designation.

Nov. 13, 2024 — An international team of scientists has identified a surprising factor that accelerates the degradation of lithium-ion batteries leading to a steady loss of charge. This ...

Hailing from Belgharia in Kolkata, 22-year-old Sayan Ghosh had traveled to Bangladesh on November 23. He stayed with a friend’s family.

Nov. 28, 2024 — The increased use of a chemical compound to replace TNT in explosive devices has a damaging and long lasting effect on plants, new research has ... Global Food Yields Have Grown ...

California is about to become home to the nation’s second electric vehicle-charging roadway — with construction due to be completed ahead of the 2028 Olympics in Los Angeles.